Nipro Renal Soultions USA, Corporation vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for Nipro Renal Soultions USA, Corporation.

Nipro Renal Soultions USA, Corporation: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

Nipro Renal Soultions USA, Corporation — Warning letters0

Philips North America — Warning letters0

Nipro Renal Soultions USA, Corporation — Recalls4

Philips North America — Recalls355

Nipro Renal Soultions USA, Corporation — Approval records0

Philips North America — Approval records0

Nipro Renal Soultions USA, Corporation — Form 483s0

Philips North America — Form 483s0

Timeline

Nipro Renal Soultions USA, Corporation

Most recent FDA action: September 16, 2026

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Nipro Renal Soultions USA, Corporation vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed September 23, 2026. https://argushq.ai/compare/nipro-renal-soultions-usa-corporation-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗